EFFICACY AND TOLERABILITY OF MOCLOBEMIDE COMPARED WITH IMIPRAMINE IN DEPRESSIVE DISORDER (DSM-III) - AN AUSTRIAN DOUBLE-BLIND, MULTICENTER STUDY

被引：97
|
作者：
BAUMHACKL, U
BIZIERE, K
FISCHBACH, R
GERETSEGGER, C
HEBENSTREIT, G
RADMAYR, E
STABL, M
机构：
[1] LANDESKRANKENHAUS PSYCHOL & NEUROL,MAUER,AUSTRIA
[2] FACHARZT NEUROL,DORNBIRN,AUSTRIA
[3] LANDES NERVENKLIN,NEUROL ABT,SALZBURG,AUSTRIA
[4] F HOFFMANN LA ROCHE & CO LTD,CH-4002 BASEL,SWITZERLAND
[5] LANDES NERVENKLIN,PSYCH KRANKENABT,SALZBURG,AUSTRIA
来源：
BRITISH JOURNAL OF PSYCHIATRY | 1989年 / 155卷
关键词：
D O I：
10.1192/S0007125000297535
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：78 / 83
页数：6
相关论文
共 50 条
  • [1] EFFICACY AND TOLERABILITY OF MOCLOBEMIDE COMPARED WITH FLUVOXAMINE IN DEPRESSIVE DISORDER (DSM III) - A FRENCH SWISS DOUBLE-BLIND TRIAL
    BOUGEROL, T
    UCHIDA, C
    GACHOUD, JP
    KOHLER, M
    MIKKELSEN, H
    [J]. PSYCHOPHARMACOLOGY, 1992, 106 : S102 - S108
  • [2] EFFICACY AND SAFETY OF MOCLOBEMIDE COMPARED WITH MAPROTILINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDER - A DOUBLE-BLIND MULTICENTER STUDY WITH PARALLEL GROUPS
    STEINMEYER, EM
    VORBACH, EU
    ARNOLDT, KH
    [J]. PHARMACOPSYCHIATRY, 1993, 26 (06) : 246 - 253
  • [3] Efficacy and tolerability of reboxetine compared with citalopram -: A double-blind study in patients with major depressive disorder
    Langworth, S
    Bodlund, O
    Ågren, H
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (02) : 121 - 127
  • [4] Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive episodes
    Berzewski, H
    VanMoffaert, M
    Gagiano, CA
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1997, 7 : S37 - S47
  • [5] MOCLOBEMIDE VERSUS IMIPRAMINE IN DEPRESSED OUT-PATIENTS - A DOUBLE-BLIND MULTICENTER STUDY
    RIMON, R
    JAASKELAINEN, J
    KAARTINEN, P
    KALLI, A
    KILPONEN, E
    KOSKINEN, T
    NIKKILA, H
    PIRTTIPERA, V
    SEPPALA, J
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1993, 7 (3-4) : 141 - 147
  • [6] A DOUBLE-BLIND COMPARATIVE TRIAL OF MOCLOBEMIDE V IMIPRAMINE AND PLACEBO IN MAJOR DEPRESSIVE EPISODES
    VERSIANI, M
    OGGERO, U
    ALTERWAIN, P
    CAPPONI, R
    DAJAS, F
    HEINZEMARTIN, G
    MARQUEZ, CA
    POLEO, MA
    RIVEROALMANZOR, LE
    ROSSEL, L
    SCHMIDBURGK, W
    UDABE, RU
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1989, 155 : 72 - 77
  • [7] Efficacy and tolerability of mirtazapine versus citalopram:: a double-blind, randomized study in patients with major depressive disorder
    Leinonen, E
    Skarstein, J
    Behnke, K
    Ågren, H
    Helsdingen, JT
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1999, 14 (06) : 329 - 337
  • [8] ROLIPRAM IN MAJOR DEPRESSIVE DISORDER - RESULTS OF A DOUBLE-BLIND COMPARATIVE-STUDY WITH IMIPRAMINE
    HEBENSTREIT, GF
    FELLERER, K
    FICHTE, K
    FISCHER, G
    GEYER, N
    MEYA, U
    SASTREYHERNANDEZ, M
    SCHONY, W
    SCHRATZER, M
    SOUKOP, W
    TRAMPITSCH, E
    VAROSANEC, S
    ZAWADA, E
    ZOCHLING, R
    [J]. PHARMACOPSYCHIATRY, 1989, 22 (04) : 156 - 160
  • [9] Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children
    La Rosa, M
    Leonardi, S
    Marchese, G
    Corrias, A
    Barberio, G
    Oggiano, N
    Grimaldi, I
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 87 (01) : 48 - 53
  • [10] The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study
    Wang, Xiaoliang
    Fan, Yimin
    Li, Guanjun
    Li, Huafang
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 133 - 139
12345